VRM
NEO icon

Vectors Research Management’s NeoGenomics NEO Stock Holding History

Vectors Research Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-126
Closed -$6K – 504
2021
Q1 		$6K Sell
126
-66
-34% -$3.44K ﹤0.01% 378
2020
Q4 		$10K Hold
192
– – ﹤0.01% 329
2020
Q3 		$7K Hold
192
– – ﹤0.01% 321
2020
Q2 		$6K Buy
+192
New +$5.32K ﹤0.01% 336

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vectors Research Management's NEO Position: Q2 2021 in Review

Vectors Research Management sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 126 shares — an estimated $6K sold.

Vectors Research Management first reported a position in NEO in Q2 2020 and held it in 4 quarters. The position peaked at $10K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

  • Vectors Research Management reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
  • Vectors Research Management sold 126 NeoGenomics shares in Q2 2021, an estimated $6K.
  • Vectors Research Management first reported a position in NeoGenomics in Q2 2020 and held it in 4 quarters.
  • Vectors Research Management's NeoGenomics position peaked at $10K in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on Vectors Research Management's 13F filing for Q2 2021, filed 9 Aug 2021.